文献速递妇科产科

HPV与细胞学联合筛查结果与子宫内膜癌及卵巢癌诊断的关系

The relationship of human papillomavirus and cytology co-testing results with endometrial and ovarian cancer diagnoses.
PubMed 文献 · Gynecol Oncol · 2021-01-14

该研究基于Kaiser Permanente北加州2003至2017年30岁以上女性的三联联合筛查数据(n=2,385,729),链接后续子宫内膜癌(n=3434)和卵巢癌(n=1113)诊断。大多数子宫内膜癌(82.18%)和卵巢癌(88.68%)之前为HPV阴性且细胞学阴性的联合筛查结果,异常筛查结果极少预测这两种癌症。

要点

  • 大多数子宫内膜癌和卵巢癌之前为HPV阴性且细胞学阴性的联合筛查。
  • ASC-US+且HPV阴性后子宫内膜癌绝对风险为0.48%。
  • AGC且HPV阴性后子宫内膜癌绝对风险4.02%,但仅1.13%的2型EC无症状者有此结果。

核心结论

  • 异常宫颈筛查测试,即使AGC细胞学,极少先于子宫内膜癌或卵巢癌诊断且预测效果差。

主要发现

  • 82.18%的子宫内膜癌和88.68%的卵巢癌之前为HPV阴性且细胞学阴性的联合筛查。
  • 子宫内膜癌前有ASC-US+细胞学且HPV阴性(n=290,占EC的8.44%)多于细胞学阴性且HPV阳性(n=31,占EC的0.89%)(p<0.001)。
  • ASC-US+且HPV阴性后任何子宫内膜癌诊断的绝对风险为0.48%。
  • AGC细胞学且HPV阴性先于6.92%的任何子宫内膜癌诊断,绝对风险4.02%;在无症状女性中,仅先于1.13%的2型子宫内膜癌,绝对风险0.24%。
  • AGC细胞学且HPV阴性先于1.44%的卵巢癌,绝对风险0.28%。

临床怎么用

  • 宫颈联合筛查结果异常,包括AGC,对子宫内膜癌或卵巢癌的预测价值有限,不应作为这些癌症的筛查工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To investigate whether routine cervical screening using human papillomavirus (HPV) and cytology co-testing effectively identifies women with endometrial (EC) or ovarian (OvC) cancer. METHODS: In 2003, Kaiser Permanente Northern California implemented triennial co-testing in women aged ≥30 years. Index screening results (n = 2,385,729) were linked to subsequent EC (n = 3434) and OvC (n = 1113) diagnoses from January 1, 2003 to December 31, 2017. EC were categorized as type 1 or 2, and, selectively, EC and OvC diagnoses were stratified on whether symptoms were present at the time of the co-test. Fractions and absolute risks of EC or OvC of each co-testing result were calculated. RESULTS: Most EC (82.18%) and OvC (88.68%) were preceded by a negative HPV and negative cytology co-test. More EC were preceded by atypical squamous cells of undetermined significance (ASC-US) or more severe (ASC-US+) cytology and negative HPV test (n = 290) (8.44% of EC) compared to a negative cytology and a positive HPV test (n = 31) (0.89% of EC) (p < 0.001). The absolute risk of any EC diagnosis following ASC-US+ and negative HPV test was 0.48%. Atypical glandular cells (AGC) cytology and a negative HPV result preceded 6.92% of any EC diagnosis, with an absolute risk of 4.02%, but preceded only 1.13% of type 2 EC cases, with an absolute risk of 0.24%, in asymptomatic women. AGC cytology and a negative HPV result preceded 1.44% of OvC, with an absolute risk of 0.28%. CONCLUSIONS: Abnormal cervical screening tests, even AGC cytology, rarely precedes and poorly predict women with EC or OvC.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Castle PE, Locke A, Tergas AI, et al. The relationship of human papillomavirus and cytology co-testing results with endometrial and ovarian cancer diagnoses. Gynecol Oncol. 2021. PMID: 33454132. doi:10.1016/j.ygyno.2021.01.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。